In 2017 CBDepot introduced the world’s first natural, isolated GMP CBD. This API became the tender winner in 2017 and 2019 for the pediatric hospital and Institute of Oncology in Ljubljana. This Active Pharmaceutical Ingredient is available for your clinical trials, pharmacy-compounded preparations, or medicinal products.
Since the introduction of the world’s first EU-GMP isolated CBD, we are constantly working to broaden our portfolio of DAB and DAC-compliant GMP cannabis extractives and isolates, including Cannabidiolum isolated, synthesized, Cannabis Extractum Normatum, and Dronabinolum.